Tumor-Antigen-Independent Targeting of Solid Tumors by Armored Macrophage-Directed Anti-TREM2 CAR T Cells

Scientist developed a macrophage-directed CAR T strategy targeting TREM2+ immunosuppressive tumor associated macrophages, achieving potent in vitro activity and robust antitumor efficacy in vivo.